Molecular Infectious Disease Testing Market

The molecular infectious disease testing market involves advanced diagnostic techniques that analyze the genetic material of pathogens for precise, early identification. The primary customers are diagnostic laboratories, hospitals, and clinics. Key growth drivers include the increasing adoption of efficient multiplex diagnostics that test for multiple pathogens at once, the rising demand for rapid testing solutions, and the integration of automation and AI to improve accuracy and scalability.

CAGR

13.5%

Compound Annual Growth Rate

Current Value

$12.6B

Estimated 2026

Projected Value

$34.7B

By 2034